Clinical trial

Carboplatin-cyclophosphamide Combined With Atezolizumab

NCT02914470

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-01

PhasePHASE1

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2021-10-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Cervix Cancerunresolved

Ovarian Cancerunresolved

Endometrial Cancerunresolved

Interventions

carbplatin, cyclophophamide, atezolizumabDRUG

Sponsors & collaborators

The Netherlands Cancer Institutelead sponsor

Roche Pharma AGcollaborator

Mapped research locations

AmsterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02914470 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.